companydata.dkcompanydata.dk

TEBU-BIO ApS: Financial statements 2024

CVR: 10156920

Source: annual report 2024, Danish Business Authority

01/01/2024 – 31/12/2024

TEBU-BIO ApS (CVR 10156920) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 1,098,153 and a net result of DKK -60,754 compared with DKK 71,151 the year before. That is a decrease of 30.4% compared with the year before. Equity in the 2024 report amounted to DKK 401,386. The solvency ratio was 31.8%. The company had 2 employees in the financial year.

Gross Profit
DKK 1,098,153
Profit/Loss
DKK -60,754
Equity
DKK 401,386
Total Assets
DKK 1,261,988
Employees
2

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2024-1.1 mio.-61 t.401 t.2
2023-1.6 mio.71 t.462 t.2
2022-1.1 mio.218 t.391 t.2
2021-1.5 mio.761 t.923 t.1
2020-1.2 mio.472 t.683 t.1

Official annual report

View the official annual report directly on the page with a Pro subscription.

Screen every Danish company

Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.

Try company screening

Events in 2024

TEBU-BIO ApS: The 2023 annual report is outJul 1, 2024

TEBU-BIO ApS has published its annual report for 2023. Gross profit came to DKK 1,577,642, and the net result was DKK 71,151.

About TEBU-BIO ApS

TEBU-BIO ApS is a Danish company of the type Anpartsselskab based in Roskilde, founded in 2003. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Donald van Dijk. The company is owned by Tebu bio S.A.. The company has 1 employee (2018). In 2025, the company reported a gross profit of DKK 1,064,139 and a net result of DKK -414,038 compared with DKK -60,754 the year before. Equity in the 2025 report amounted to DKK -12,652.

Source: annual report 2025, Danish Business Authority